Nanobac Historical Financial Ratios
| NNBP Stock | USD 0.0001 0.00 0.00% |
Nanobac Pharmaceuticals is lately reporting on over 61 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Average Payables of 394.7 K will help investors to properly organize and evaluate Nanobac Pharmaceuticals financial condition quickly.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. About Nanobac Financial Ratios Analysis
Nanobac PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Nanobac Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Nanobac financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Nanobac Pharmaceuticals history.
Nanobac Pharmaceuticals Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Nanobac Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Nanobac Pharmaceuticals sales, a figure that is much harder to manipulate than other Nanobac Pharmaceuticals Incorporated multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Nanobac Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Nanobac Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. At this time, Nanobac Pharmaceuticals' ROE is relatively stable compared to the past year.
| 2010 | 2011 | 2024 | 2025 (projected) | Payables Turnover | 3.2 | 0.0135 | 0.0155 | 0.0147 | Days Of Inventory On Hand | 239.29 | 259.01 | 233.11 | 168.33 |
Nanobac Pharmaceuticals fundamentals Correlations
Click cells to compare fundamentals
Nanobac Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Additional Tools for Nanobac Stock Analysis
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.